nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Thrombophlebitis—Memantine—Alzheimer's disease	0.00462	0.00462	CcSEcCtD
Tobramycin—Blood alkaline phosphatase increased—Memantine—Alzheimer's disease	0.0046	0.0046	CcSEcCtD
Tobramycin—Ear pain—Rivastigmine—Alzheimer's disease	0.00459	0.00459	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.00457	0.00457	CcSEcCtD
Tobramycin—Thrombophlebitis—Rivastigmine—Alzheimer's disease	0.00452	0.00452	CcSEcCtD
Tobramycin—Blood alkaline phosphatase increased—Rivastigmine—Alzheimer's disease	0.0045	0.0045	CcSEcCtD
Tobramycin—Disorientation—Memantine—Alzheimer's disease	0.00448	0.00448	CcSEcCtD
Tobramycin—Deafness—Memantine—Alzheimer's disease	0.00448	0.00448	CcSEcCtD
Tobramycin—Weight decreased—Galantamine—Alzheimer's disease	0.00445	0.00445	CcSEcCtD
Tobramycin—Eye pain—Memantine—Alzheimer's disease	0.00443	0.00443	CcSEcCtD
Tobramycin—Deafness—Rivastigmine—Alzheimer's disease	0.00438	0.00438	CcSEcCtD
Tobramycin—Eye pain—Rivastigmine—Alzheimer's disease	0.00434	0.00434	CcSEcCtD
Tobramycin—Renal failure acute—Memantine—Alzheimer's disease	0.00434	0.00434	CcSEcCtD
Tobramycin—Renal failure—Galantamine—Alzheimer's disease	0.00431	0.00431	CcSEcCtD
Tobramycin—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.0043	0.0043	CcSEcCtD
Tobramycin—Renal failure acute—Rivastigmine—Alzheimer's disease	0.00424	0.00424	CcSEcCtD
Tobramycin—Renal impairment—Memantine—Alzheimer's disease	0.00421	0.00421	CcSEcCtD
Tobramycin—Epistaxis—Galantamine—Alzheimer's disease	0.00414	0.00414	CcSEcCtD
Tobramycin—Blood creatinine increased—Donepezil—Alzheimer's disease	0.00413	0.00413	CcSEcCtD
Tobramycin—Renal impairment—Rivastigmine—Alzheimer's disease	0.00412	0.00412	CcSEcCtD
Tobramycin—Dehydration—Donepezil—Alzheimer's disease	0.0041	0.0041	CcSEcCtD
Tobramycin—Lethargy—Memantine—Alzheimer's disease	0.00409	0.00409	CcSEcCtD
Tobramycin—Dry skin—Donepezil—Alzheimer's disease	0.00404	0.00404	CcSEcCtD
Tobramycin—Hypokalaemia—Donepezil—Alzheimer's disease	0.00401	0.00401	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Donepezil—Alzheimer's disease	0.00397	0.00397	CcSEcCtD
Tobramycin—Rhinitis—Galantamine—Alzheimer's disease	0.00395	0.00395	CcSEcCtD
Tobramycin—Muscular weakness—Donepezil—Alzheimer's disease	0.00389	0.00389	CcSEcCtD
Tobramycin—Urinary tract disorder—Galantamine—Alzheimer's disease	0.00389	0.00389	CcSEcCtD
Tobramycin—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00387	0.00387	CcSEcCtD
Tobramycin—Urethral disorder—Galantamine—Alzheimer's disease	0.00386	0.00386	CcSEcCtD
Tobramycin—Asthma—Donepezil—Alzheimer's disease	0.00381	0.00381	CcSEcCtD
Tobramycin—Visual impairment—Galantamine—Alzheimer's disease	0.00379	0.00379	CcSEcCtD
Tobramycin—Eosinophilia—Donepezil—Alzheimer's disease	0.00377	0.00377	CcSEcCtD
Tobramycin—Blood creatinine increased—Memantine—Alzheimer's disease	0.00375	0.00375	CcSEcCtD
Tobramycin—Dehydration—Memantine—Alzheimer's disease	0.00372	0.00372	CcSEcCtD
Tobramycin—Eye disorder—Galantamine—Alzheimer's disease	0.00368	0.00368	CcSEcCtD
Tobramycin—Tinnitus—Galantamine—Alzheimer's disease	0.00367	0.00367	CcSEcCtD
Tobramycin—Dry skin—Memantine—Alzheimer's disease	0.00367	0.00367	CcSEcCtD
Tobramycin—Bronchitis—Donepezil—Alzheimer's disease	0.00367	0.00367	CcSEcCtD
Tobramycin—Hypokalaemia—Memantine—Alzheimer's disease	0.00364	0.00364	CcSEcCtD
Tobramycin—Dehydration—Rivastigmine—Alzheimer's disease	0.00364	0.00364	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.00361	0.00361	CcSEcCtD
Tobramycin—Dry skin—Rivastigmine—Alzheimer's disease	0.00359	0.00359	CcSEcCtD
Tobramycin—Angiopathy—Galantamine—Alzheimer's disease	0.00357	0.00357	CcSEcCtD
Tobramycin—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.00356	0.00356	CcSEcCtD
Tobramycin—Immune system disorder—Galantamine—Alzheimer's disease	0.00356	0.00356	CcSEcCtD
Tobramycin—Muscular weakness—Memantine—Alzheimer's disease	0.00353	0.00353	CcSEcCtD
Tobramycin—Asthma—Memantine—Alzheimer's disease	0.00346	0.00346	CcSEcCtD
Tobramycin—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00345	0.00345	CcSEcCtD
Tobramycin—Weight decreased—Donepezil—Alzheimer's disease	0.00345	0.00345	CcSEcCtD
Tobramycin—Bronchospasm—Memantine—Alzheimer's disease	0.0034	0.0034	CcSEcCtD
Tobramycin—Infestation NOS—Donepezil—Alzheimer's disease	0.0034	0.0034	CcSEcCtD
Tobramycin—Infestation—Donepezil—Alzheimer's disease	0.0034	0.0034	CcSEcCtD
Tobramycin—Dysgeusia—Galantamine—Alzheimer's disease	0.00336	0.00336	CcSEcCtD
Tobramycin—Renal failure—Donepezil—Alzheimer's disease	0.00334	0.00334	CcSEcCtD
Tobramycin—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00333	0.00333	CcSEcCtD
Tobramycin—Bronchitis—Memantine—Alzheimer's disease	0.00333	0.00333	CcSEcCtD
Tobramycin—Back pain—Galantamine—Alzheimer's disease	0.00331	0.00331	CcSEcCtD
Tobramycin—Bronchitis—Rivastigmine—Alzheimer's disease	0.00326	0.00326	CcSEcCtD
Tobramycin—Vision blurred—Galantamine—Alzheimer's disease	0.00323	0.00323	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00322	0.00322	CcSEcCtD
Tobramycin—Epistaxis—Donepezil—Alzheimer's disease	0.00321	0.00321	CcSEcCtD
Tobramycin—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00318	0.00318	CcSEcCtD
Tobramycin—Anaemia—Galantamine—Alzheimer's disease	0.00317	0.00317	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.00315	0.00315	CcSEcCtD
Tobramycin—Weight decreased—Memantine—Alzheimer's disease	0.00313	0.00313	CcSEcCtD
Tobramycin—Malaise—Galantamine—Alzheimer's disease	0.00309	0.00309	CcSEcCtD
Tobramycin—Infestation NOS—Memantine—Alzheimer's disease	0.00309	0.00309	CcSEcCtD
Tobramycin—Infestation—Memantine—Alzheimer's disease	0.00309	0.00309	CcSEcCtD
Tobramycin—Vertigo—Galantamine—Alzheimer's disease	0.00308	0.00308	CcSEcCtD
Tobramycin—Weight decreased—Rivastigmine—Alzheimer's disease	0.00306	0.00306	CcSEcCtD
Tobramycin—Rhinitis—Donepezil—Alzheimer's disease	0.00306	0.00306	CcSEcCtD
Tobramycin—Renal failure—Memantine—Alzheimer's disease	0.00303	0.00303	CcSEcCtD
Tobramycin—Pharyngitis—Donepezil—Alzheimer's disease	0.00303	0.00303	CcSEcCtD
Tobramycin—Neuropathy peripheral—Memantine—Alzheimer's disease	0.00302	0.00302	CcSEcCtD
Tobramycin—Infestation—Rivastigmine—Alzheimer's disease	0.00302	0.00302	CcSEcCtD
Tobramycin—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00302	0.00302	CcSEcCtD
Tobramycin—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00301	0.00301	CcSEcCtD
Tobramycin—Urethral disorder—Donepezil—Alzheimer's disease	0.00299	0.00299	CcSEcCtD
Tobramycin—Cough—Galantamine—Alzheimer's disease	0.00299	0.00299	CcSEcCtD
Tobramycin—Renal failure—Rivastigmine—Alzheimer's disease	0.00297	0.00297	CcSEcCtD
Tobramycin—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.00296	0.00296	CcSEcCtD
Tobramycin—Visual impairment—Donepezil—Alzheimer's disease	0.00294	0.00294	CcSEcCtD
Tobramycin—Chest pain—Galantamine—Alzheimer's disease	0.00292	0.00292	CcSEcCtD
Tobramycin—Myalgia—Galantamine—Alzheimer's disease	0.00292	0.00292	CcSEcCtD
Tobramycin—Epistaxis—Memantine—Alzheimer's disease	0.00291	0.00291	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.0029	0.0029	CcSEcCtD
Tobramycin—Sinusitis—Memantine—Alzheimer's disease	0.00289	0.00289	CcSEcCtD
Tobramycin—Discomfort—Galantamine—Alzheimer's disease	0.00288	0.00288	CcSEcCtD
Tobramycin—Agranulocytosis—Memantine—Alzheimer's disease	0.00288	0.00288	CcSEcCtD
Tobramycin—Epistaxis—Rivastigmine—Alzheimer's disease	0.00285	0.00285	CcSEcCtD
Tobramycin—Tinnitus—Donepezil—Alzheimer's disease	0.00284	0.00284	CcSEcCtD
Tobramycin—Sinusitis—Rivastigmine—Alzheimer's disease	0.00283	0.00283	CcSEcCtD
Tobramycin—Confusional state—Galantamine—Alzheimer's disease	0.00282	0.00282	CcSEcCtD
Tobramycin—Rhinitis—Memantine—Alzheimer's disease	0.00278	0.00278	CcSEcCtD
Tobramycin—Pharyngitis—Memantine—Alzheimer's disease	0.00275	0.00275	CcSEcCtD
Tobramycin—Nervous system disorder—Galantamine—Alzheimer's disease	0.00274	0.00274	CcSEcCtD
Tobramycin—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00274	0.00274	CcSEcCtD
Tobramycin—Urinary tract disorder—Memantine—Alzheimer's disease	0.00274	0.00274	CcSEcCtD
Tobramycin—Connective tissue disorder—Memantine—Alzheimer's disease	0.00272	0.00272	CcSEcCtD
Tobramycin—Rhinitis—Rivastigmine—Alzheimer's disease	0.00272	0.00272	CcSEcCtD
Tobramycin—Skin disorder—Galantamine—Alzheimer's disease	0.00272	0.00272	CcSEcCtD
Tobramycin—Urethral disorder—Memantine—Alzheimer's disease	0.00271	0.00271	CcSEcCtD
Tobramycin—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00269	0.00269	CcSEcCtD
Tobramycin—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00268	0.00268	CcSEcCtD
Tobramycin—Visual impairment—Memantine—Alzheimer's disease	0.00267	0.00267	CcSEcCtD
Tobramycin—Anorexia—Galantamine—Alzheimer's disease	0.00267	0.00267	CcSEcCtD
Tobramycin—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00266	0.00266	CcSEcCtD
Tobramycin—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00266	0.00266	CcSEcCtD
Tobramycin—Erythema—Donepezil—Alzheimer's disease	0.00266	0.00266	CcSEcCtD
Tobramycin—Visual impairment—Rivastigmine—Alzheimer's disease	0.00261	0.00261	CcSEcCtD
Tobramycin—Dysgeusia—Donepezil—Alzheimer's disease	0.0026	0.0026	CcSEcCtD
Tobramycin—Eye disorder—Memantine—Alzheimer's disease	0.00259	0.00259	CcSEcCtD
Tobramycin—Tinnitus—Memantine—Alzheimer's disease	0.00258	0.00258	CcSEcCtD
Tobramycin—Back pain—Donepezil—Alzheimer's disease	0.00257	0.00257	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00255	0.00255	CcSEcCtD
Tobramycin—Eye disorder—Rivastigmine—Alzheimer's disease	0.00253	0.00253	CcSEcCtD
Tobramycin—Tinnitus—Rivastigmine—Alzheimer's disease	0.00253	0.00253	CcSEcCtD
Tobramycin—Angiopathy—Memantine—Alzheimer's disease	0.00251	0.00251	CcSEcCtD
Tobramycin—Paraesthesia—Galantamine—Alzheimer's disease	0.00251	0.00251	CcSEcCtD
Tobramycin—Vision blurred—Donepezil—Alzheimer's disease	0.0025	0.0025	CcSEcCtD
Tobramycin—Immune system disorder—Memantine—Alzheimer's disease	0.0025	0.0025	CcSEcCtD
Tobramycin—Mediastinal disorder—Memantine—Alzheimer's disease	0.0025	0.0025	CcSEcCtD
Tobramycin—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00246	0.00246	CcSEcCtD
Tobramycin—Angiopathy—Rivastigmine—Alzheimer's disease	0.00246	0.00246	CcSEcCtD
Tobramycin—Anaemia—Donepezil—Alzheimer's disease	0.00245	0.00245	CcSEcCtD
Tobramycin—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00244	0.00244	CcSEcCtD
Tobramycin—Decreased appetite—Galantamine—Alzheimer's disease	0.00243	0.00243	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00241	0.00241	CcSEcCtD
Tobramycin—Malaise—Donepezil—Alzheimer's disease	0.00239	0.00239	CcSEcCtD
Tobramycin—Vertigo—Donepezil—Alzheimer's disease	0.00239	0.00239	CcSEcCtD
Tobramycin—Dysgeusia—Memantine—Alzheimer's disease	0.00236	0.00236	CcSEcCtD
Tobramycin—Erythema—Rivastigmine—Alzheimer's disease	0.00236	0.00236	CcSEcCtD
Tobramycin—Back pain—Memantine—Alzheimer's disease	0.00233	0.00233	CcSEcCtD
Tobramycin—Cough—Donepezil—Alzheimer's disease	0.00232	0.00232	CcSEcCtD
Tobramycin—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00231	0.00231	CcSEcCtD
Tobramycin—Feeling abnormal—Galantamine—Alzheimer's disease	0.0023	0.0023	CcSEcCtD
Tobramycin—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00229	0.00229	CcSEcCtD
Tobramycin—Back pain—Rivastigmine—Alzheimer's disease	0.00228	0.00228	CcSEcCtD
Tobramycin—Vision blurred—Memantine—Alzheimer's disease	0.00227	0.00227	CcSEcCtD
Tobramycin—Myalgia—Donepezil—Alzheimer's disease	0.00226	0.00226	CcSEcCtD
Tobramycin—Chest pain—Donepezil—Alzheimer's disease	0.00226	0.00226	CcSEcCtD
Tobramycin—Ill-defined disorder—Memantine—Alzheimer's disease	0.00224	0.00224	CcSEcCtD
Tobramycin—Discomfort—Donepezil—Alzheimer's disease	0.00223	0.00223	CcSEcCtD
Tobramycin—Anaemia—Memantine—Alzheimer's disease	0.00223	0.00223	CcSEcCtD
Tobramycin—Vision blurred—Rivastigmine—Alzheimer's disease	0.00222	0.00222	CcSEcCtD
Tobramycin—Abdominal pain—Galantamine—Alzheimer's disease	0.00221	0.00221	CcSEcCtD
Tobramycin—Body temperature increased—Galantamine—Alzheimer's disease	0.00221	0.00221	CcSEcCtD
Tobramycin—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00219	0.00219	CcSEcCtD
Tobramycin—Confusional state—Donepezil—Alzheimer's disease	0.00219	0.00219	CcSEcCtD
Tobramycin—Anaemia—Rivastigmine—Alzheimer's disease	0.00218	0.00218	CcSEcCtD
Tobramycin—Malaise—Memantine—Alzheimer's disease	0.00217	0.00217	CcSEcCtD
Tobramycin—Vertigo—Memantine—Alzheimer's disease	0.00217	0.00217	CcSEcCtD
Tobramycin—Leukopenia—Memantine—Alzheimer's disease	0.00216	0.00216	CcSEcCtD
Tobramycin—Malaise—Rivastigmine—Alzheimer's disease	0.00213	0.00213	CcSEcCtD
Tobramycin—Nervous system disorder—Donepezil—Alzheimer's disease	0.00213	0.00213	CcSEcCtD
Tobramycin—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00212	0.00212	CcSEcCtD
Tobramycin—Vertigo—Rivastigmine—Alzheimer's disease	0.00212	0.00212	CcSEcCtD
Tobramycin—Cough—Memantine—Alzheimer's disease	0.0021	0.0021	CcSEcCtD
Tobramycin—Anorexia—Donepezil—Alzheimer's disease	0.00207	0.00207	CcSEcCtD
Tobramycin—Hypersensitivity—Galantamine—Alzheimer's disease	0.00206	0.00206	CcSEcCtD
Tobramycin—Cough—Rivastigmine—Alzheimer's disease	0.00206	0.00206	CcSEcCtD
Tobramycin—Myalgia—Memantine—Alzheimer's disease	0.00205	0.00205	CcSEcCtD
Tobramycin—Chest pain—Memantine—Alzheimer's disease	0.00205	0.00205	CcSEcCtD
Tobramycin—Discomfort—Memantine—Alzheimer's disease	0.00203	0.00203	CcSEcCtD
Tobramycin—Chest pain—Rivastigmine—Alzheimer's disease	0.00201	0.00201	CcSEcCtD
Tobramycin—Myalgia—Rivastigmine—Alzheimer's disease	0.00201	0.00201	CcSEcCtD
Tobramycin—Asthenia—Galantamine—Alzheimer's disease	0.00201	0.00201	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00199	0.00199	CcSEcCtD
Tobramycin—Confusional state—Memantine—Alzheimer's disease	0.00198	0.00198	CcSEcCtD
Tobramycin—Discomfort—Rivastigmine—Alzheimer's disease	0.00198	0.00198	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00197	0.00197	CcSEcCtD
Tobramycin—Paraesthesia—Donepezil—Alzheimer's disease	0.00195	0.00195	CcSEcCtD
Tobramycin—Confusional state—Rivastigmine—Alzheimer's disease	0.00194	0.00194	CcSEcCtD
Tobramycin—Dyspnoea—Donepezil—Alzheimer's disease	0.00193	0.00193	CcSEcCtD
Tobramycin—Nervous system disorder—Memantine—Alzheimer's disease	0.00193	0.00193	CcSEcCtD
Tobramycin—Thrombocytopenia—Memantine—Alzheimer's disease	0.00193	0.00193	CcSEcCtD
Tobramycin—Diarrhoea—Galantamine—Alzheimer's disease	0.00191	0.00191	CcSEcCtD
Tobramycin—Skin disorder—Memantine—Alzheimer's disease	0.00191	0.00191	CcSEcCtD
Tobramycin—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00189	0.00189	CcSEcCtD
Tobramycin—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00188	0.00188	CcSEcCtD
Tobramycin—Decreased appetite—Donepezil—Alzheimer's disease	0.00188	0.00188	CcSEcCtD
Tobramycin—Anorexia—Memantine—Alzheimer's disease	0.00188	0.00188	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00187	0.00187	CcSEcCtD
Tobramycin—Skin disorder—Rivastigmine—Alzheimer's disease	0.00187	0.00187	CcSEcCtD
Tobramycin—Pain—Donepezil—Alzheimer's disease	0.00185	0.00185	CcSEcCtD
Tobramycin—Dizziness—Galantamine—Alzheimer's disease	0.00185	0.00185	CcSEcCtD
Tobramycin—Anorexia—Rivastigmine—Alzheimer's disease	0.00183	0.00183	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00179	0.00179	CcSEcCtD
Tobramycin—Feeling abnormal—Donepezil—Alzheimer's disease	0.00179	0.00179	CcSEcCtD
Tobramycin—Vomiting—Galantamine—Alzheimer's disease	0.00178	0.00178	CcSEcCtD
Tobramycin—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00177	0.00177	CcSEcCtD
Tobramycin—Paraesthesia—Memantine—Alzheimer's disease	0.00177	0.00177	CcSEcCtD
Tobramycin—Rash—Galantamine—Alzheimer's disease	0.00176	0.00176	CcSEcCtD
Tobramycin—Dermatitis—Galantamine—Alzheimer's disease	0.00176	0.00176	CcSEcCtD
Tobramycin—Dyspnoea—Memantine—Alzheimer's disease	0.00175	0.00175	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00175	0.00175	CcSEcCtD
Tobramycin—Headache—Galantamine—Alzheimer's disease	0.00175	0.00175	CcSEcCtD
Tobramycin—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00173	0.00173	CcSEcCtD
Tobramycin—Urticaria—Donepezil—Alzheimer's disease	0.00172	0.00172	CcSEcCtD
Tobramycin—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00172	0.00172	CcSEcCtD
Tobramycin—Body temperature increased—Donepezil—Alzheimer's disease	0.00171	0.00171	CcSEcCtD
Tobramycin—Abdominal pain—Donepezil—Alzheimer's disease	0.00171	0.00171	CcSEcCtD
Tobramycin—Decreased appetite—Memantine—Alzheimer's disease	0.00171	0.00171	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.0017	0.0017	CcSEcCtD
Tobramycin—Pain—Memantine—Alzheimer's disease	0.00168	0.00168	CcSEcCtD
Tobramycin—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00167	0.00167	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00166	0.00166	CcSEcCtD
Tobramycin—Nausea—Galantamine—Alzheimer's disease	0.00166	0.00166	CcSEcCtD
Tobramycin—Pain—Rivastigmine—Alzheimer's disease	0.00165	0.00165	CcSEcCtD
Tobramycin—Feeling abnormal—Memantine—Alzheimer's disease	0.00162	0.00162	CcSEcCtD
Tobramycin—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00161	0.00161	CcSEcCtD
Tobramycin—Hypersensitivity—Donepezil—Alzheimer's disease	0.0016	0.0016	CcSEcCtD
Tobramycin—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00159	0.00159	CcSEcCtD
Tobramycin—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00157	0.00157	CcSEcCtD
Tobramycin—Urticaria—Memantine—Alzheimer's disease	0.00156	0.00156	CcSEcCtD
Tobramycin—Body temperature increased—Memantine—Alzheimer's disease	0.00156	0.00156	CcSEcCtD
Tobramycin—Abdominal pain—Memantine—Alzheimer's disease	0.00156	0.00156	CcSEcCtD
Tobramycin—Asthenia—Donepezil—Alzheimer's disease	0.00155	0.00155	CcSEcCtD
Tobramycin—Pruritus—Donepezil—Alzheimer's disease	0.00153	0.00153	CcSEcCtD
Tobramycin—Urticaria—Rivastigmine—Alzheimer's disease	0.00153	0.00153	CcSEcCtD
Tobramycin—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00152	0.00152	CcSEcCtD
Tobramycin—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00152	0.00152	CcSEcCtD
Tobramycin—Diarrhoea—Donepezil—Alzheimer's disease	0.00148	0.00148	CcSEcCtD
Tobramycin—Hypersensitivity—Memantine—Alzheimer's disease	0.00145	0.00145	CcSEcCtD
Tobramycin—Dizziness—Donepezil—Alzheimer's disease	0.00143	0.00143	CcSEcCtD
Tobramycin—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00142	0.00142	CcSEcCtD
Tobramycin—Asthenia—Memantine—Alzheimer's disease	0.00141	0.00141	CcSEcCtD
Tobramycin—Pruritus—Memantine—Alzheimer's disease	0.00139	0.00139	CcSEcCtD
Tobramycin—Asthenia—Rivastigmine—Alzheimer's disease	0.00138	0.00138	CcSEcCtD
Tobramycin—Vomiting—Donepezil—Alzheimer's disease	0.00138	0.00138	CcSEcCtD
Tobramycin—Rash—Donepezil—Alzheimer's disease	0.00137	0.00137	CcSEcCtD
Tobramycin—Dermatitis—Donepezil—Alzheimer's disease	0.00137	0.00137	CcSEcCtD
Tobramycin—Pruritus—Rivastigmine—Alzheimer's disease	0.00136	0.00136	CcSEcCtD
Tobramycin—Headache—Donepezil—Alzheimer's disease	0.00136	0.00136	CcSEcCtD
Tobramycin—Diarrhoea—Memantine—Alzheimer's disease	0.00135	0.00135	CcSEcCtD
Tobramycin—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00132	0.00132	CcSEcCtD
Tobramycin—Dizziness—Memantine—Alzheimer's disease	0.0013	0.0013	CcSEcCtD
Tobramycin—Nausea—Donepezil—Alzheimer's disease	0.00129	0.00129	CcSEcCtD
Tobramycin—Dizziness—Rivastigmine—Alzheimer's disease	0.00127	0.00127	CcSEcCtD
Tobramycin—Vomiting—Memantine—Alzheimer's disease	0.00125	0.00125	CcSEcCtD
Tobramycin—Rash—Memantine—Alzheimer's disease	0.00124	0.00124	CcSEcCtD
Tobramycin—Dermatitis—Memantine—Alzheimer's disease	0.00124	0.00124	CcSEcCtD
Tobramycin—Headache—Memantine—Alzheimer's disease	0.00123	0.00123	CcSEcCtD
Tobramycin—Vomiting—Rivastigmine—Alzheimer's disease	0.00122	0.00122	CcSEcCtD
Tobramycin—Rash—Rivastigmine—Alzheimer's disease	0.00121	0.00121	CcSEcCtD
Tobramycin—Dermatitis—Rivastigmine—Alzheimer's disease	0.00121	0.00121	CcSEcCtD
Tobramycin—Headache—Rivastigmine—Alzheimer's disease	0.00121	0.00121	CcSEcCtD
Tobramycin—Nausea—Memantine—Alzheimer's disease	0.00117	0.00117	CcSEcCtD
Tobramycin—Nausea—Rivastigmine—Alzheimer's disease	0.00114	0.00114	CcSEcCtD
